OrangerV1, PascalFrancis, Corpus, bibRecord, 000078

Ceramides as Possible Nutraceutical Compounds: Characterization of the Ceramides of the Moro Blood Orange (Citrus sinensis)

Identifieur interne : 000078 ( PascalFrancis/Corpus ); précédent : 000077; suivant : 000079

Ceramides as Possible Nutraceutical Compounds: Characterization of the Ceramides of the Moro Blood Orange (Citrus sinensis)

Auteurs : Manuela Valsecchi ; Laura Mauri ; Riccardo Casellato ; Maria Grazia Ciampa ; Luisa Rizza ; Andrea Bonina ; Francesco Bonina ; Sandro Sonnino

Source :

Journal of agricultural and food chemistry : (Print) [ 0021-8561 ] ; 2012.

RBID : Pascal:12-0417967

Descripteurs français

Pascal (Inist)
- Caractérisation, Sang, Orange, Citrus sinensis, Pelure, Pulpe, Cosmétique, Peau.

English descriptors

KwdEn :
- Blood, Characterization, Citrus sinensis, Cosmetic, Orange, Peel, Pulp, Skin.

Abstract

Ceramides are presented as nutraceutical compounds for protection of colon carcinoma and as important cosmetic preparation components, increasing absorption through the skin. Therefore, the ceramide (Cer) content of Moro blood oranges was determined by mass spectrometry. A total of 114 Cer species were identified: ∼160 mg in the peels and ∼140 mg in the pulp per kilogram of oranges, expressed as "milligram equivalents of d18:1,17:0 Cer". The predominant ceramides contained 4-hydroxy-8-sphingenine (t18:1^Δ8) and 4-hydroxysphinganine (t18:0) as long-chain bases (LCBs) and fatty acids (FAs) with different structures. In the pulp, t18:1^Δ8- and t18:0-containing Cer species comprised 50.5 and 33.5% of the total, respectively, 11.5 and 3.5% non-hydroxylated FAs, respectively, 32.0 and 21.0% α-hydroxylated FAs, respectively, and 7.0 and 9.0% α,β-hydroxylated FAs, respectively. In the peels, t18:1^Δ8- and t18:0-containing species comprised 49.5 and 34.5% of the total, respectively, 16.0 and 1.5% non-hydroxylated FAs, respectively, 31.5 and 29.0% α-hydroxylated FAs, respectively, and 2.0 and 4.0% α,β-hydroxylated FAs, respectively.

Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

A01	`01`	`1`		`@0 0021-8561`
A02	`01`			`@0 JAFCAU`
A03		`1`		`@0 J. agric. food chem. : (Print)`
A05				`@2 60`
A06				`@2 40`
A08	`01`	`1`	`ENG`	`@1 Ceramides as Possible Nutraceutical Compounds: Characterization of the Ceramides of the Moro Blood Orange (Citrus sinensis)`
A11	`01`	`1`		`@1 VALSECCHI (Manuela)`
A11	`02`	`1`		`@1 MAURI (Laura)`
A11	`03`	`1`		`@1 CASELLATO (Riccardo)`
A11	`04`	`1`		`@1 GRAZIA CIAMPA (Maria)`
A11	`05`	`1`		`@1 RIZZA (Luisa)`
A11	`06`	`1`		`@1 BONINA (Andrea)`
A11	`07`	`1`		`@1 BONINA (Francesco)`
A11	`08`	`1`		`@1 SONNINO (Sandro)`
A14	`01`			`@1 Department of Medical Biotechnology and Translational Medicine, University of Milan, Via Fratelli Cervi 93 @2 20090 Segrate (Milan) @3 ITA @Z 1 aut. @Z 2 aut. @Z 3 aut. @Z 4 aut. @Z 8 aut.`
A14	`02`			`@1 Research and Development, Bionap Srl, Via Badalà 6 @2 95010 Santa Venerina (Catania) @3 ITA @Z 5 aut. @Z 6 aut.`
A14	`03`			`@1 Department of Drug Sciences, University of Catania, Viale Andrea Doria 6 @2 95125 Catania @3 ITA @Z 7 aut.`
A20				`@1 10103-10110`
A21				`@1 2012`
A23	`01`			`@0 ENG`
A43	`01`			`@1 INIST @2 7332 @5 354000505338930210`
A44				`@0 0000 @1 © 2012 INIST-CNRS. All rights reserved.`
A45				`@0 40 ref.`
A47	`01`	`1`		`@0 12-0417967`
A60				`@1 P`
A61				`@0 A`
A64	`01`	`1`		`@0 Journal of agricultural and food chemistry : (Print)`
A66	`01`			`@0 USA`
C01	`01`		`ENG`	@0 Ceramides are presented as nutraceutical compounds for protection of colon carcinoma and as important cosmetic preparation components, increasing absorption through the skin. Therefore, the ceramide (Cer) content of Moro blood oranges was determined by mass spectrometry. A total of 114 Cer species were identified: ∼160 mg in the peels and ∼140 mg in the pulp per kilogram of oranges, expressed as "milligram equivalents of d18:1,17:0 Cer". The predominant ceramides contained 4-hydroxy-8-sphingenine (t18:1^Δ8) and 4-hydroxysphinganine (t18:0) as long-chain bases (LCBs) and fatty acids (FAs) with different structures. In the pulp, t18:1^Δ8- and t18:0-containing Cer species comprised 50.5 and 33.5% of the total, respectively, 11.5 and 3.5% non-hydroxylated FAs, respectively, 32.0 and 21.0% α-hydroxylated FAs, respectively, and 7.0 and 9.0% α,β-hydroxylated FAs, respectively. In the peels, t18:1^Δ8- and t18:0-containing species comprised 49.5 and 34.5% of the total, respectively, 16.0 and 1.5% non-hydroxylated FAs, respectively, 31.5 and 29.0% α-hydroxylated FAs, respectively, and 2.0 and 4.0% α,β-hydroxylated FAs, respectively.
C02	`01`	`X`		`@0 002A35B09`
C03	`01`	`X`	`FRE`	`@0 Caractérisation @5 01`
C03	`01`	`X`	`ENG`	`@0 Characterization @5 01`
C03	`01`	`X`	`SPA`	`@0 Caracterización @5 01`
C03	`02`	`X`	`FRE`	`@0 Sang @5 02`
C03	`02`	`X`	`ENG`	`@0 Blood @5 02`
C03	`02`	`X`	`SPA`	`@0 Sangre @5 02`
C03	`03`	`X`	`FRE`	`@0 Orange @5 10`
C03	`03`	`X`	`ENG`	`@0 Orange @5 10`
C03	`03`	`X`	`SPA`	`@0 Naranja @5 10`
C03	`04`	`X`	`FRE`	`@0 Citrus sinensis @2 NS @5 11`
C03	`04`	`X`	`ENG`	`@0 Citrus sinensis @2 NS @5 11`
C03	`04`	`X`	`SPA`	`@0 Citrus sinensis @2 NS @5 11`
C03	`05`	`X`	`FRE`	`@0 Pelure @5 12`
C03	`05`	`X`	`ENG`	`@0 Peel @5 12`
C03	`05`	`X`	`SPA`	`@0 Cáscara @5 12`
C03	`06`	`X`	`FRE`	`@0 Pulpe @5 19`
C03	`06`	`X`	`ENG`	`@0 Pulp @5 19`
C03	`06`	`X`	`SPA`	`@0 Pulpa @5 19`
C03	`07`	`X`	`FRE`	`@0 Cosmétique @2 FX @5 20`
C03	`07`	`X`	`ENG`	`@0 Cosmetic @2 FX @5 20`
C03	`07`	`X`	`SPA`	`@0 Cosmético @2 FX @5 20`
C03	`08`	`X`	`FRE`	`@0 Peau @5 21`
C03	`08`	`X`	`ENG`	`@0 Skin @5 21`
C03	`08`	`X`	`SPA`	`@0 Piel @5 21`
C07	`01`	`X`	`FRE`	`@0 Fruit @5 08`
C07	`01`	`X`	`ENG`	`@0 Fruit @5 08`
C07	`01`	`X`	`SPA`	`@0 Fruto @5 08`
C07	`02`	`X`	`FRE`	`@0 Rutaceae @2 NS`
C07	`02`	`X`	`ENG`	`@0 Rutaceae @2 NS`
C07	`02`	`X`	`SPA`	`@0 Rutaceae @2 NS`
C07	`03`	`X`	`FRE`	`@0 Dicotyledones @2 NS`
C07	`03`	`X`	`ENG`	`@0 Dicotyledones @2 NS`
C07	`03`	`X`	`SPA`	`@0 Dicotyledones @2 NS`
C07	`04`	`X`	`FRE`	`@0 Angiospermae @2 NS`
C07	`04`	`X`	`ENG`	`@0 Angiospermae @2 NS`
C07	`04`	`X`	`SPA`	`@0 Angiospermae @2 NS`
C07	`05`	`X`	`FRE`	`@0 Spermatophyta @2 NS`
C07	`05`	`X`	`ENG`	`@0 Spermatophyta @2 NS`
C07	`05`	`X`	`SPA`	`@0 Spermatophyta @2 NS`
C07	`06`	`X`	`FRE`	`@0 Agrume @5 49`
C07	`06`	`X`	`ENG`	`@0 Citrus fruit @5 49`
C07	`06`	`X`	`SPA`	`@0 Agrios @5 49`
N21				`@1 324`
N44	`01`			`@1 OTO`
N82				`@1 OTO`

Format Inist (serveur)

NO :	PASCAL 12-0417967 INIST
ET :	Ceramides as Possible Nutraceutical Compounds: Characterization of the Ceramides of the Moro Blood Orange (Citrus sinensis)
AU :	VALSECCHI (Manuela); MAURI (Laura); CASELLATO (Riccardo); GRAZIA CIAMPA (Maria); RIZZA (Luisa); BONINA (Andrea); BONINA (Francesco); SONNINO (Sandro)
AF :	Department of Medical Biotechnology and Translational Medicine, University of Milan, Via Fratelli Cervi 93/20090 Segrate (Milan)/Italie (1 aut., 2 aut., 3 aut., 4 aut., 8 aut.); Research and Development, Bionap Srl, Via Badalà 6/95010 Santa Venerina (Catania)/Italie (5 aut., 6 aut.); Department of Drug Sciences, University of Catania, Viale Andrea Doria 6/95125 Catania/Italie (7 aut.)
DT :	Publication en série; Niveau analytique
SO :	Journal of agricultural and food chemistry : (Print); ISSN 0021-8561; Coden JAFCAU; Etats-Unis; Da. 2012; Vol. 60; No. 40; Pp. 10103-10110; Bibl. 40 ref.
LA :	Anglais
EA :	Ceramides are presented as nutraceutical compounds for protection of colon carcinoma and as important cosmetic preparation components, increasing absorption through the skin. Therefore, the ceramide (Cer) content of Moro blood oranges was determined by mass spectrometry. A total of 114 Cer species were identified: ∼160 mg in the peels and ∼140 mg in the pulp per kilogram of oranges, expressed as "milligram equivalents of d18:1,17:0 Cer". The predominant ceramides contained 4-hydroxy-8-sphingenine (t18:1^Δ8) and 4-hydroxysphinganine (t18:0) as long-chain bases (LCBs) and fatty acids (FAs) with different structures. In the pulp, t18:1^Δ8- and t18:0-containing Cer species comprised 50.5 and 33.5% of the total, respectively, 11.5 and 3.5% non-hydroxylated FAs, respectively, 32.0 and 21.0% α-hydroxylated FAs, respectively, and 7.0 and 9.0% α,β-hydroxylated FAs, respectively. In the peels, t18:1^Δ8- and t18:0-containing species comprised 49.5 and 34.5% of the total, respectively, 16.0 and 1.5% non-hydroxylated FAs, respectively, 31.5 and 29.0% α-hydroxylated FAs, respectively, and 2.0 and 4.0% α,β-hydroxylated FAs, respectively.
CC :	002A35B09
FD :	Caractérisation; Sang; Orange; Citrus sinensis; Pelure; Pulpe; Cosmétique; Peau
FG :	Fruit; Rutaceae; Dicotyledones; Angiospermae; Spermatophyta; Agrume
ED :	Characterization; Blood; Orange; Citrus sinensis; Peel; Pulp; Cosmetic; Skin
EG :	Fruit; Rutaceae; Dicotyledones; Angiospermae; Spermatophyta; Citrus fruit
SD :	Caracterización; Sangre; Naranja; Citrus sinensis; Cáscara; Pulpa; Cosmético; Piel
LO :	INIST-7332.354000505338930210
ID :	12-0417967

Links to Exploration step

Pascal:12-0417967

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Ceramides as Possible Nutraceutical Compounds: Characterization of the Ceramides of the Moro Blood Orange (Citrus sinensis)</title>
<author><name sortKey="Valsecchi, Manuela" sort="Valsecchi, Manuela" uniqKey="Valsecchi M" first="Manuela" last="Valsecchi">Manuela Valsecchi</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Medical Biotechnology and Translational Medicine, University of Milan, Via Fratelli Cervi 93</s1>
<s2>20090 Segrate (Milan)</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Mauri, Laura" sort="Mauri, Laura" uniqKey="Mauri L" first="Laura" last="Mauri">Laura Mauri</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Medical Biotechnology and Translational Medicine, University of Milan, Via Fratelli Cervi 93</s1>
<s2>20090 Segrate (Milan)</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Casellato, Riccardo" sort="Casellato, Riccardo" uniqKey="Casellato R" first="Riccardo" last="Casellato">Riccardo Casellato</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Medical Biotechnology and Translational Medicine, University of Milan, Via Fratelli Cervi 93</s1>
<s2>20090 Segrate (Milan)</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Grazia Ciampa, Maria" sort="Grazia Ciampa, Maria" uniqKey="Grazia Ciampa M" first="Maria" last="Grazia Ciampa">Maria Grazia Ciampa</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Medical Biotechnology and Translational Medicine, University of Milan, Via Fratelli Cervi 93</s1>
<s2>20090 Segrate (Milan)</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Rizza, Luisa" sort="Rizza, Luisa" uniqKey="Rizza L" first="Luisa" last="Rizza">Luisa Rizza</name>
<affiliation><inist:fA14 i1="02"><s1>Research and Development, Bionap Srl, Via Badalà 6</s1>
<s2>95010 Santa Venerina (Catania)</s2>
<s3>ITA</s3>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Bonina, Andrea" sort="Bonina, Andrea" uniqKey="Bonina A" first="Andrea" last="Bonina">Andrea Bonina</name>
<affiliation><inist:fA14 i1="02"><s1>Research and Development, Bionap Srl, Via Badalà 6</s1>
<s2>95010 Santa Venerina (Catania)</s2>
<s3>ITA</s3>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Bonina, Francesco" sort="Bonina, Francesco" uniqKey="Bonina F" first="Francesco" last="Bonina">Francesco Bonina</name>
<affiliation><inist:fA14 i1="03"><s1>Department of Drug Sciences, University of Catania, Viale Andrea Doria 6</s1>
<s2>95125 Catania</s2>
<s3>ITA</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Sonnino, Sandro" sort="Sonnino, Sandro" uniqKey="Sonnino S" first="Sandro" last="Sonnino">Sandro Sonnino</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Medical Biotechnology and Translational Medicine, University of Milan, Via Fratelli Cervi 93</s1>
<s2>20090 Segrate (Milan)</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">12-0417967</idno>
<date when="2012">2012</date>
<idno type="stanalyst">PASCAL 12-0417967 INIST</idno>
<idno type="RBID">Pascal:12-0417967</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000078</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Ceramides as Possible Nutraceutical Compounds: Characterization of the Ceramides of the Moro Blood Orange (Citrus sinensis)</title>
<author><name sortKey="Valsecchi, Manuela" sort="Valsecchi, Manuela" uniqKey="Valsecchi M" first="Manuela" last="Valsecchi">Manuela Valsecchi</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Medical Biotechnology and Translational Medicine, University of Milan, Via Fratelli Cervi 93</s1>
<s2>20090 Segrate (Milan)</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Mauri, Laura" sort="Mauri, Laura" uniqKey="Mauri L" first="Laura" last="Mauri">Laura Mauri</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Medical Biotechnology and Translational Medicine, University of Milan, Via Fratelli Cervi 93</s1>
<s2>20090 Segrate (Milan)</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Casellato, Riccardo" sort="Casellato, Riccardo" uniqKey="Casellato R" first="Riccardo" last="Casellato">Riccardo Casellato</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Medical Biotechnology and Translational Medicine, University of Milan, Via Fratelli Cervi 93</s1>
<s2>20090 Segrate (Milan)</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Grazia Ciampa, Maria" sort="Grazia Ciampa, Maria" uniqKey="Grazia Ciampa M" first="Maria" last="Grazia Ciampa">Maria Grazia Ciampa</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Medical Biotechnology and Translational Medicine, University of Milan, Via Fratelli Cervi 93</s1>
<s2>20090 Segrate (Milan)</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Rizza, Luisa" sort="Rizza, Luisa" uniqKey="Rizza L" first="Luisa" last="Rizza">Luisa Rizza</name>
<affiliation><inist:fA14 i1="02"><s1>Research and Development, Bionap Srl, Via Badalà 6</s1>
<s2>95010 Santa Venerina (Catania)</s2>
<s3>ITA</s3>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Bonina, Andrea" sort="Bonina, Andrea" uniqKey="Bonina A" first="Andrea" last="Bonina">Andrea Bonina</name>
<affiliation><inist:fA14 i1="02"><s1>Research and Development, Bionap Srl, Via Badalà 6</s1>
<s2>95010 Santa Venerina (Catania)</s2>
<s3>ITA</s3>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Bonina, Francesco" sort="Bonina, Francesco" uniqKey="Bonina F" first="Francesco" last="Bonina">Francesco Bonina</name>
<affiliation><inist:fA14 i1="03"><s1>Department of Drug Sciences, University of Catania, Viale Andrea Doria 6</s1>
<s2>95125 Catania</s2>
<s3>ITA</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Sonnino, Sandro" sort="Sonnino, Sandro" uniqKey="Sonnino S" first="Sandro" last="Sonnino">Sandro Sonnino</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Medical Biotechnology and Translational Medicine, University of Milan, Via Fratelli Cervi 93</s1>
<s2>20090 Segrate (Milan)</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Journal of agricultural and food chemistry : (Print)</title>
<title level="j" type="abbreviated">J. agric. food chem. : (Print)</title>
<idno type="ISSN">0021-8561</idno>
<imprint><date when="2012">2012</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Journal of agricultural and food chemistry : (Print)</title>
<title level="j" type="abbreviated">J. agric. food chem. : (Print)</title>
<idno type="ISSN">0021-8561</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Blood</term>
<term>Characterization</term>
<term>Citrus sinensis</term>
<term>Cosmetic</term>
<term>Orange</term>
<term>Peel</term>
<term>Pulp</term>
<term>Skin</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Caractérisation</term>
<term>Sang</term>
<term>Orange</term>
<term>Citrus sinensis</term>
<term>Pelure</term>
<term>Pulpe</term>
<term>Cosmétique</term>
<term>Peau</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Ceramides are presented as nutraceutical compounds for protection of colon carcinoma and as important cosmetic preparation components, increasing absorption through the skin. Therefore, the ceramide (Cer) content of Moro blood oranges was determined by mass spectrometry. A total of 114 Cer species were identified: ∼160 mg in the peels and ∼140 mg in the pulp per kilogram of oranges, expressed as "milligram equivalents of d18:1,17:0 Cer". The predominant ceramides contained 4-hydroxy-8-sphingenine (t18:1<sup>Δ8</sup>
) and 4-hydroxysphinganine (t18:0) as long-chain bases (LCBs) and fatty acids (FAs) with different structures. In the pulp, t18:1<sup>Δ8</sup>
- and t18:0-containing Cer species comprised 50.5 and 33.5% of the total, respectively, 11.5 and 3.5% non-hydroxylated FAs, respectively, 32.0 and 21.0% α-hydroxylated FAs, respectively, and 7.0 and 9.0% α,β-hydroxylated FAs, respectively. In the peels, t18:1<sup>Δ8</sup>
- and t18:0-containing species comprised 49.5 and 34.5% of the total, respectively, 16.0 and 1.5% non-hydroxylated FAs, respectively, 31.5 and 29.0% α-hydroxylated FAs, respectively, and 2.0 and 4.0% α,β-hydroxylated FAs, respectively.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0021-8561</s0>
</fA01>
<fA02 i1="01"><s0>JAFCAU</s0>
</fA02>
<fA03 i2="1"><s0>J. agric. food chem. : (Print)</s0>
</fA03>
<fA05><s2>60</s2>
</fA05>
<fA06><s2>40</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Ceramides as Possible Nutraceutical Compounds: Characterization of the Ceramides of the Moro Blood Orange (Citrus sinensis)</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>VALSECCHI (Manuela)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>MAURI (Laura)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>CASELLATO (Riccardo)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>GRAZIA CIAMPA (Maria)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>RIZZA (Luisa)</s1>
</fA11>
<fA11 i1="06" i2="1"><s1>BONINA (Andrea)</s1>
</fA11>
<fA11 i1="07" i2="1"><s1>BONINA (Francesco)</s1>
</fA11>
<fA11 i1="08" i2="1"><s1>SONNINO (Sandro)</s1>
</fA11>
<fA14 i1="01"><s1>Department of Medical Biotechnology and Translational Medicine, University of Milan, Via Fratelli Cervi 93</s1>
<s2>20090 Segrate (Milan)</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>8 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>Research and Development, Bionap Srl, Via Badalà 6</s1>
<s2>95010 Santa Venerina (Catania)</s2>
<s3>ITA</s3>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>Department of Drug Sciences, University of Catania, Viale Andrea Doria 6</s1>
<s2>95125 Catania</s2>
<s3>ITA</s3>
<sZ>7 aut.</sZ>
</fA14>
<fA20><s1>10103-10110</s1>
</fA20>
<fA21><s1>2012</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>7332</s2>
<s5>354000505338930210</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2012 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>40 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>12-0417967</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Journal of agricultural and food chemistry : (Print)</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>Ceramides are presented as nutraceutical compounds for protection of colon carcinoma and as important cosmetic preparation components, increasing absorption through the skin. Therefore, the ceramide (Cer) content of Moro blood oranges was determined by mass spectrometry. A total of 114 Cer species were identified: ∼160 mg in the peels and ∼140 mg in the pulp per kilogram of oranges, expressed as "milligram equivalents of d18:1,17:0 Cer". The predominant ceramides contained 4-hydroxy-8-sphingenine (t18:1<sup>Δ8</sup>
) and 4-hydroxysphinganine (t18:0) as long-chain bases (LCBs) and fatty acids (FAs) with different structures. In the pulp, t18:1<sup>Δ8</sup>
- and t18:0-containing Cer species comprised 50.5 and 33.5% of the total, respectively, 11.5 and 3.5% non-hydroxylated FAs, respectively, 32.0 and 21.0% α-hydroxylated FAs, respectively, and 7.0 and 9.0% α,β-hydroxylated FAs, respectively. In the peels, t18:1<sup>Δ8</sup>
- and t18:0-containing species comprised 49.5 and 34.5% of the total, respectively, 16.0 and 1.5% non-hydroxylated FAs, respectively, 31.5 and 29.0% α-hydroxylated FAs, respectively, and 2.0 and 4.0% α,β-hydroxylated FAs, respectively.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002A35B09</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Caractérisation</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Characterization</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Caracterización</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Sang</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Blood</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Sangre</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Orange</s0>
<s5>10</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Orange</s0>
<s5>10</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Naranja</s0>
<s5>10</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Citrus sinensis</s0>
<s2>NS</s2>
<s5>11</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Citrus sinensis</s0>
<s2>NS</s2>
<s5>11</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Citrus sinensis</s0>
<s2>NS</s2>
<s5>11</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Pelure</s0>
<s5>12</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Peel</s0>
<s5>12</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Cáscara</s0>
<s5>12</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Pulpe</s0>
<s5>19</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Pulp</s0>
<s5>19</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Pulpa</s0>
<s5>19</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Cosmétique</s0>
<s2>FX</s2>
<s5>20</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Cosmetic</s0>
<s2>FX</s2>
<s5>20</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Cosmético</s0>
<s2>FX</s2>
<s5>20</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE"><s0>Peau</s0>
<s5>21</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG"><s0>Skin</s0>
<s5>21</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA"><s0>Piel</s0>
<s5>21</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Fruit</s0>
<s5>08</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Fruit</s0>
<s5>08</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Fruto</s0>
<s5>08</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Rutaceae</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Rutaceae</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Rutaceae</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Dicotyledones</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Dicotyledones</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Dicotyledones</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Angiospermae</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Angiospermae</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Angiospermae</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="05" i2="X" l="FRE"><s0>Spermatophyta</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="05" i2="X" l="ENG"><s0>Spermatophyta</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="05" i2="X" l="SPA"><s0>Spermatophyta</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="06" i2="X" l="FRE"><s0>Agrume</s0>
<s5>49</s5>
</fC07>
<fC07 i1="06" i2="X" l="ENG"><s0>Citrus fruit</s0>
<s5>49</s5>
</fC07>
<fC07 i1="06" i2="X" l="SPA"><s0>Agrios</s0>
<s5>49</s5>
</fC07>
<fN21><s1>324</s1>
</fN21>
<fN44 i1="01"><s1>OTO</s1>
</fN44>
<fN82><s1>OTO</s1>
</fN82>
</pA>
</standard>
<server><NO>PASCAL 12-0417967 INIST</NO>
<ET>Ceramides as Possible Nutraceutical Compounds: Characterization of the Ceramides of the Moro Blood Orange (Citrus sinensis)</ET>
<AU>VALSECCHI (Manuela); MAURI (Laura); CASELLATO (Riccardo); GRAZIA CIAMPA (Maria); RIZZA (Luisa); BONINA (Andrea); BONINA (Francesco); SONNINO (Sandro)</AU>
<AF>Department of Medical Biotechnology and Translational Medicine, University of Milan, Via Fratelli Cervi 93/20090 Segrate (Milan)/Italie (1 aut., 2 aut., 3 aut., 4 aut., 8 aut.); Research and Development, Bionap Srl, Via Badalà 6/95010 Santa Venerina (Catania)/Italie (5 aut., 6 aut.); Department of Drug Sciences, University of Catania, Viale Andrea Doria 6/95125 Catania/Italie (7 aut.)</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>Journal of agricultural and food chemistry : (Print); ISSN 0021-8561; Coden JAFCAU; Etats-Unis; Da. 2012; Vol. 60; No. 40; Pp. 10103-10110; Bibl. 40 ref.</SO>
<LA>Anglais</LA>
<EA>Ceramides are presented as nutraceutical compounds for protection of colon carcinoma and as important cosmetic preparation components, increasing absorption through the skin. Therefore, the ceramide (Cer) content of Moro blood oranges was determined by mass spectrometry. A total of 114 Cer species were identified: ∼160 mg in the peels and ∼140 mg in the pulp per kilogram of oranges, expressed as "milligram equivalents of d18:1,17:0 Cer". The predominant ceramides contained 4-hydroxy-8-sphingenine (t18:1<sup>Δ8</sup>
) and 4-hydroxysphinganine (t18:0) as long-chain bases (LCBs) and fatty acids (FAs) with different structures. In the pulp, t18:1<sup>Δ8</sup>
- and t18:0-containing Cer species comprised 50.5 and 33.5% of the total, respectively, 11.5 and 3.5% non-hydroxylated FAs, respectively, 32.0 and 21.0% α-hydroxylated FAs, respectively, and 7.0 and 9.0% α,β-hydroxylated FAs, respectively. In the peels, t18:1<sup>Δ8</sup>
- and t18:0-containing species comprised 49.5 and 34.5% of the total, respectively, 16.0 and 1.5% non-hydroxylated FAs, respectively, 31.5 and 29.0% α-hydroxylated FAs, respectively, and 2.0 and 4.0% α,β-hydroxylated FAs, respectively.</EA>
<CC>002A35B09</CC>
<FD>Caractérisation; Sang; Orange; Citrus sinensis; Pelure; Pulpe; Cosmétique; Peau</FD>
<FG>Fruit; Rutaceae; Dicotyledones; Angiospermae; Spermatophyta; Agrume</FG>
<ED>Characterization; Blood; Orange; Citrus sinensis; Peel; Pulp; Cosmetic; Skin</ED>
<EG>Fruit; Rutaceae; Dicotyledones; Angiospermae; Spermatophyta; Citrus fruit</EG>
<SD>Caracterización; Sangre; Naranja; Citrus sinensis; Cáscara; Pulpa; Cosmético; Piel</SD>
<LO>INIST-7332.354000505338930210</LO>
<ID>12-0417967</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Bois/explor/OrangerV1/Data/PascalFrancis/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000078 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 000078 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Bois
   |area=    OrangerV1
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Pascal:12-0417967
   |texte=   Ceramides as Possible Nutraceutical Compounds: Characterization of the Ceramides of the Moro Blood Orange (Citrus sinensis)
}}

This area was generated with Dilib version V0.6.25.
Data generation: Sat Dec 3 17:11:04 2016. Site generation: Wed Mar 6 18:18:32 2024

	Serveur d'exploration sur l'oranger
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur l'oranger

Ceramides as Possible Nutraceutical Compounds: Characterization of the Ceramides of the Moro Blood Orange (Citrus sinensis)

Ceramides as Possible Nutraceutical Compounds: Characterization of the Ceramides of the Moro Blood Orange (Citrus sinensis)

Source :

Descripteurs français

English descriptors

Abstract

Notice en format standard (ISO 2709)

Format Inist (serveur)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri